Cecilia O’Kane

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials”.

Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials

The Lancet Respiratory Medicine(2020)10.1016/s2213-2600(19)30369-8

N/A

0DataRank · unranked

316 citations

Kevin Delucchi, Daniel F. McAuley, Cecilia O’Kane, Michael A. Matthay, Carolyn S. Calfee +1 more

Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study

The Lancet Respiratory Medicine(2020)10.1016/s2213-2600(20)30366-0

N/A

0DataRank · unranked

268 citations

Carolyn S. Calfee, Shiney Cherian, David Brealey, Sean Cutler, Charles C. King +13 more

Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy — Achieving global consensus and visibility for cellular host-directed therapies

International Journal of Infectious Diseases(2020)10.1016/j.ijid.2020.05.040

N/A

0DataRank · unranked

49 citations

Fu‐Sheng Wang, Giuseppe Ippolito, Nicola Petrosillo, Chiara Agrati, Esam I. Azhar +12 more

Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases

Clinical Microbiology Reviews(2021)10.1128/cmr.00064-21

N/A

0DataRank · unranked

36 citations

Anna Krasnodembskaya, Gunnar N. Schroeder, Alimuddin Zumla, Markus Maeurer, Cecilia O’Kane +1 more

Defining phenotypes and treatment effect heterogeneity to inform acute respiratory distress syndrome and sepsis trials: secondary analyses of three RCTs

Efficacy and Mechanism Evaluation(2021)10.3310/eme08100

N/A

0DataRank · unranked

26 citations

Shalini Santhakumaran, A Toby Prevost, Josie K Ward, Timothy J Marshall, Claire Bradley +11 more

The relationship between plasma cystatin C, mortality and acute respiratory distress syndrome subphenotype in the HARP-2 trial

Critical Care and Resuscitation(2022)10.51893/2022.3.oa4

N/A

0DataRank · unranked

1 citations

Ian Bradbury, Clíona McDowell, Carolyn S. Calfee, Sinéad Weldon, Cecilia O’Kane +3 more

Effect of total cholesterol and statin therapy on mortality in ARDS patients: a secondary analysis of the SAILS and HARP-2 trials

Critical Care(2023)10.1186/s13054-023-04387-9

N/A

0DataRank · unranked

32 citations

A. R. Moore, Jiazhen Guan, Joseph E. Levitt, Michael A. Matthay, Rebecca M. Baron +5 more

Elevated Plasma Interleukin-18 Identifies High-Risk Acute Respiratory Distress Syndrome Patients not Distinguished by Prior Latent Class Analyses Using Traditional Inflammatory Cytokines: A Retrospective Analysis of Two Randomized Clinical Trials

Critical Care Medicine(2023)10.1097/ccm.0000000000006028

N/A

0DataRank · unranked

22 citations

S. Pienkos, Pratik Sinha, Jiazhen Guan, Cecilia O’Kane, Joseph E. Levitt +8 more